The meth crisis is worse than ever, but new treatments might be around the corner
When it comes to meth addiction, Thomas Robey has long been at a loss. As an emergency room doctor, he treats a steady stream of patients who show up at …
Read MoreBiotech
U.S. to spend more than $2 billion to launch Biden’s biomanufacturing initiative
The federal government is pledging more than $2 billion to launch President Biden’s new national biomanufacturing initiative, funding efforts to build or expand drug manufacturing sites in the U.S. and …
Read More
Roche pays $250 million to acquire Good Therapeutics and its preclinical cancer therapy
Good Therapeutics, a private company that raised just $30 million in venture financing since its 2016 foundation, said Wednesday it had signed a deal to sell itself to Roche for …
Read More
Moderna sues Pfizer and BioNTech over Covid-19 vaccine
Moderna on Friday sued Pfizer and BioNTech, its main rivals in the mRNA Covid vaccine race, for allegedly infringing on its patents, the latest and perhaps most significant in a …
Read More
Drug companies could create new drugs to protect the Covid vulnerable. Why aren’t they?
Twice, Janet Handal thought she would get a reprieve from semi-lockdown life. The first was when she was vaccinated in January, 2021. But a negative antibody test quickly dashed those …
Read More
As new variant spreads, a crucial drug to protect the most vulnerable goes vastly underused
Jennifer Padgett has spent 2 1/2 years terrified for her immunocompromised daughter, Hannah. Hannah catches pneumonia like mosquito bites; what could Covid wreak? Their whole family locked down in the …
Read More
Biotech employees cash in health care’s largest salaries, while people working at providers sit near the bottom
It pays to be in the lab. It pays way less to be at the patient’s bedside. People who work at biotechs, life sciences firms, and pharmaceutical companies pull in …
Read More
Pfizer’s Paxlovid study fails to answer key questions over benefit for broader populations
Pfizer said Tuesday that a much-watched study of its antiviral Paxlovid in patients who have Covid but don’t have risk factors for severe disease failed to show a benefit in …
Read More
Eli Lilly wins FDA approval for first-ever treatment for hair loss caused by autoimmunity
The Food and Drug Administration on Monday approved an Eli Lilly drug that is the first-ever treatment for alopecia areata, an autoimmune disorder that triggers sudden hair loss. The once-daily …
Read More